Kinetic Properties and Regulation of Biliverdin Reductase
Overview
Biophysics
Authors
Affiliations
In kinetic studies of the dual nucleotide enzyme biliverdin reductase, product inhibition patterns obtained with bilirubin as the inhibitor, using either the NADPH-linked reaction at pH 8.7 or the NADH-linked reaction at pH 7.0, are consistent with a random order of substrate addition and product release at either pH. With NAD(P) as the product inhibitor, the inhibition patterns suggest the existence of an enzyme-NAD(P)-biliverdin abortive complex. In the absence of added products, substrate inhibition observed at high biliverdin concentrations is also consistent with such a complex. Direct evidence for the existence of enzyme-NADP-biliverdin abortive complexes has been obtained at both pH 7.0 and 8.7 using the fluorescent NADP analog nicotinamide-1-N-6-ethenoadenine dinucleotide phosphate. Etheno-NADP fluorescence is enhanced in enzyme:etheno-NADP complexes but quenched in enzyme:biliverdin:etheno-NADP complexes. The effects of iron hematoporphyrin and cobalt protoporphyrin on the activity of biliverdin reductase have been examined. Iron-hematoporphyrin is a competitive inhibitor with respect to coenzyme at either pH. Comparison of Km values for biliverdin and Ki values for bilirubin or iron-hematoporphyrin indicate that while the binding of biliverdin is relatively pH independent, bilirubin binds more tightly at pH 7.0 than pH 8.7. Conversely, Fe-hematoporphyrin binds considerably tighter at pH 8.7 than pH 7.0. With cobalt-protoporphyrin, however, activation is observed, suggesting the existence of a regulatory site on biliverdin reductase for porphyrin derivatives. Resonance energy transfer measurements, from the fluorescent coenzyme analog etheno-NADP to biliverdin, iron-hematoporphyrin, or cobalt-protoporphyrin indicate that while the biliverdin site is located approximately 15 A from the etheno moiety of the coenzyme, both porphyrin derivatives are located 23.5 A away. This suggest the existence of a separate porphyrin binding site on biliverdin reductase which, depending upon the nature of the porphyrin binding, can produce activation or inhibition of the enzyme.
Gordon D, Neifer K, Hamoud A, Hawk C, Nestor-Kalinoski A, Miruzzi S J Biol Chem. 2020; 295(29):9804-9822.
PMID: 32404366 PMC: 7380202. DOI: 10.1074/jbc.RA120.013700.
Gordon D, Blomquist T, Miruzzi S, McCullumsmith R, Stec D, Hinds Jr T Physiol Genomics. 2019; 51(6):234-240.
PMID: 31074682 PMC: 6620644. DOI: 10.1152/physiolgenomics.00028.2019.
Go green: the anti-inflammatory effects of biliverdin reductase.
Wegiel B, Otterbein L Front Pharmacol. 2012; 3:47.
PMID: 22438844 PMC: 3306015. DOI: 10.3389/fphar.2012.00047.
Inhibition of nitric oxide-induced apoptosis by nicotine in oral epithelial cells.
Banerjee A, Gopalakrishnan V, Vishwanatha J Mol Cell Biochem. 2007; 305(1-2):113-21.
PMID: 17636461 DOI: 10.1007/s11010-007-9534-2.
Effect of regulated expression of the fragile histidine triad gene on cell cycle and proliferation.
Guo Z, Vishwanatha J Mol Cell Biochem. 2000; 204(1-2):83-8.
PMID: 10718628 DOI: 10.1023/a:1007068823848.